Global Molecular Diagnostics Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)
Global Molecular Diagnostics Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)
Market Segmentation: By Technology (In Situ Hybridization, Chips and Microarrays, Mass Spectrometry (MS), Sequencing, PCR, and Other Technologies), Application (Infectious Disease, Oncology, Pharmacogenomics, Microbiology, Genetic Disease Screening, Human Leukocyte Antigen Typing, and Blood Screening), Technology (Instruments, Reagents, and Other Technologies), End User (Hospitals, Laboratories, and Other End Users), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
Market Overview
The Global Molecular Diagnostics Market was valued at USD 17,059.9 million in 2023 and is expected to reach USD 42,542.4 million by 2031 while growing at a CAGR of 12.1% during the forecast period (2024-2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Market Dynamics
This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global molecular diagnostics market growth. Molecular diagnostics involves employing various techniques to analyze biological markers within the genome and proteome, facilitating the detection and characterization of genetic variations, gene expression patterns, and microbial pathogens at the molecular level.
Continuous advancements in molecular biology techniques such as PCR, nucleic acid amplification, sequencing, and microarray technologies, combined with the increasing prevalence of infectious diseases, are propelling the molecular diagnostics market forward. Nonetheless, regulatory and reimbursement challenges, along with issues surrounding data interpretation and variant classification, may pose obstacles to market growth.
Furthermore, the global molecular diagnostics industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.
Segmentation – By Technology Analysis
The Global Molecular Diagnostics Market is segmented among In Situ Hybridization, Chips and Microarrays, Mass Spectrometry, Sequencing, PCR, and Other Technologies, based on Technology. In 2023, PCR accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Segmentation – By Application Analysis
The Global Molecular Diagnostics Market is segmented among Infectious Disease, Oncology, Pharmacogenomics, Microbiology, Genetic Disease Screening, Human Leukocyte Antigen Typing, and Blood Screening, based on Application. In 2023, Infectious Disease accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Global Molecular Diagnostics Market: Regional Analysis
Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Competitive Landscape
Some of the key players operating in the market are F Hoffmann-la Roche Ltd, Illumina Ltd, Hologic Corporation, Agilent Technologies Inc., Qiagen NV, Myriad Genetics, Becton, Dickinson and Company, Abbott Laboratories, Biomerieux SA, and Bio-Rad Laboratories Inc.
Table of Contents:
1. Research Methodology and Market Scope
Research Methodology
Market Scope
2. Executive Summary
3. Global Molecular Diagnostics Market Dynamics
Drivers
Restraints
Opportunity
4. Global Molecular Diagnostics Industry Analysis
PEST Analysis
Porter's Five Force Analysis
Recent Deals Analysis
5. Global Molecular Diagnostics Market Segmentation, By Technology
Global Molecular Diagnostics Market Share Analysis, By Technology
Global Molecular Diagnostics Market Growth Analysis, By Technology
Global Molecular Diagnostics Market Trends, By Technology
o In Situ Hybridization
o Chips and Microarrays
o Mass Spectrometry (MS)
o Sequencing
o PCR
o Other Technologies
6. Global Molecular Diagnostics Market Segmentation, By Application
Global Molecular Diagnostics Market Share Analysis, By Application
Global Molecular Diagnostics Market Growth Analysis, By Application
Global Molecular Diagnostics Market Trends, By Application
o Infectious Disease
o Oncology
o Pharmacogenomics
o Microbiology
o Genetic Disease Screening
o Human Leukocyte Antigen Typing
o Blood Screening
7. Global Molecular Diagnostics Market Segmentation, By Product
Global Molecular Diagnostics Market Share Analysis, By Product
Global Molecular Diagnostics Market Growth Analysis, By Product
Global Molecular Diagnostics Market Trends, By Product
o Instruments
o Reagents
o Other Products
8. Global Molecular Diagnostics Market Segmentation, By End User
Global Molecular Diagnostics Market Share Analysis, By End User
Global Molecular Diagnostics Market Growth Analysis, By End User
Global Molecular Diagnostics Market Trends, By End User
o Hospitals
o Laboratories
o Other End Users
9. Global Molecular Diagnostics Market Segmentation, By Region
Global Molecular Diagnostics Market Share Analysis, By Region
Global Molecular Diagnostics Market Growth Analysis, By Region
Global Molecular Diagnostics Market Trends, By Region
o North America
o Europe
o Asia Pacific
o Latin America
o Middle East
o Africa
10. Competitive Landscape
F Hoffmann-la Roche Ltd*
o Company Overview
o Financial Performance
o Key Development/Strategies
o SWOT Analysis
Illumina Ltd
Hologic Corporation
Agilent Technologies Inc.
Qiagen NV
Myriad Genetics
Becton, Dickinson and Company
Abbott Laboratories
Biomerieux SA
Bio-Rad Laboratories Inc.
*Similar analysis will be provided for each company listed above.
